PHOENIX Pharmahandel GmbH & Co KG
PHOENIX Pharmahandel GmbH & Co KG, a leading pharmaceutical wholesaler, is headquartered in Germany and operates extensively across Europe. Founded in 1994, the company has established itself as a key player in the healthcare sector, focusing on the distribution of pharmaceuticals, medical products, and healthcare services. With a commitment to quality and efficiency, PHOENIX offers a diverse range of services, including logistics solutions and digital healthcare innovations. Its unique approach to supply chain management ensures that healthcare providers receive timely access to essential medications and products. Recognised for its robust market position, PHOENIX Pharmahandel has achieved significant milestones, including numerous awards for excellence in service delivery. The company continues to enhance its reputation as a trusted partner in the pharmaceutical industry, dedicated to improving patient care across its operational regions.
DitchCarbon Score
How does PHOENIX Pharmahandel GmbH & Co KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PHOENIX Pharmahandel GmbH & Co KG's score of 58 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PHOENIX Pharmahandel GmbH & Co KG currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of PHOENIX Pharmahandel SE, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from PHOENIX Pharmahandel GmbH & Co KG. The absence of specific initiatives or targets suggests that the company may still be in the early stages of formalising its climate strategy. Given the lack of emissions data and reduction initiatives, it is essential for PHOENIX Pharmahandel GmbH & Co KG to develop a comprehensive approach to carbon management, aligning with industry standards and best practices. This could include setting science-based targets and participating in initiatives such as the Carbon Disclosure Project (CDP) to enhance transparency and accountability in their climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 20,501,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 47,693,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 140,907,000 | 000,000,000 | 00,000,000 | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PHOENIX Pharmahandel GmbH & Co KG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
